 |
|
|
| |
An Evaluation of Neutropenia in the Pivotal Studies of Boceprevir Plus Peginterferon alfa-2b/Ribavirin
|
| |
| |
Reported by Jules Levin
AASLD Nov 5-8 2011 SF
K. R. Reddy1, F. Nunes2, L. Balart3, R. Sjogren4, L. D. Pedicone5, M. Burroughs5, C. Brass5, J. Albrecht5, and M. Sulkowski6
1University of Pennsylvania, Philadelphia, PA, USA; 2P.H.G.I. Associates, Ltd., Philadelphia, PA, USA; 3Tulane University Health Sciences Center, New Orleans, LA, USA; 4Kaiser Permanente, Falls Church, VA, USA; 5Merck Sharp & Dohme Corp., Whitehouse Station, NJ, USA; 6Johns Hopkins University School of Medicine, Baltimore, MD, USA
|
| |
|
|
|
|
|
